ANI Pharmaceuticals, Inc

(NASDAQ:ANIP)

Latest On ANI Pharmaceuticals, Inc (ANIP):

Date/Time Type Description Signal Details
2023-05-31 02:07 ESTNewsANI Pharmaceuticals: Strong Revenue Growth And ANDA ApprovalsN/A
2023-05-15 20:53 ESTNewsANI Pharma gains as FDA clears generics for Celontin and FosamaxN/A
2023-05-12 20:30 ESTNewsANI Pharmaceuticals down 6%, prices $75M offeringN/A
2023-05-12 06:14 ESTNewsANI Pharmaceuticals announces proposed stock offering, shares fall 6% after hoursN/A
2023-05-08 20:59 ESTNewsANI Pharmaceuticals soars ~10% after Q1 beat, raises outlook amid rare disease focusN/A
2023-05-08 20:59 ESTNewsANI Pharmaceuticals, Inc. (ANIP) Q1 2023 Earnings Call TranscriptN/A
2023-05-08 07:43 ESTNewsANI Pharmaceuticals Non-GAAP EPS of $1.17 beats by $0.82, revenue of $106.79M beats by $23.31MN/A
2023-05-05 23:59 ESTNewsANI Pharmaceuticals Q1 2023 Earnings PreviewN/A
2023-04-24 15:29 ESTNewsANI Pharmaceuticals stock rises after FDA approval of generic antibioticN/A
2023-04-04 10:27 ESTNewsANI Pharma's generic cholesterol-lowering drug gets FDA approvalN/A
2023-03-10 04:47 ESTNewsANI Pharmaceuticals, Inc. (ANIP) Q4 2022 Earnings Call TranscriptN/A
2023-03-09 13:04 ESTNewsANI Pharmaceuticals Non-GAAP EPS of $0.76 beats by $0.09, revenue of $94.2M beats by $8.06MN/A
2023-03-08 22:19 ESTNewsANI Pharmaceuticals Q4 2022 Earnings PreviewN/A
2023-03-01 22:47 ESTNewsANI Pharma draws Buy at Guggenheim on potential of autoimmune therapyN/A
2023-01-01 20:02 ESTNews2023 A Big Year For Testosterone: AbbVie And ANI Pharmaceuticals Best Positioned To BenefitN/A
2022-12-20 07:38 ESTNewsANI Pharmaceuticals gets FDA approval for generic levocarnitine tabletsN/A
2022-11-16 07:53 ESTNewsANI Pharmaceuticals launches generic antibiotic trimethoprim with FDA approval in bagN/A
2022-11-09 20:16 ESTNewsANI Pharmaceuticals reports Q3 earnings beat; reaffirms FY22 guidanceN/A
2022-11-09 20:14 ESTNewsANI Pharmaceuticals, Inc. (ANIP) Q3 2022 Earnings Call TranscriptN/A
2022-11-09 02:13 ESTNewsANI Pharmaceuticals Q3 2022 Earnings PreviewN/A
2022-09-14 00:52 ESTNewsANI Pharmaceuticals (ANIP) presents at H.C. Wainwright 24th Annual Global Investment Conference - SlideshowN/A
2022-08-30 01:03 ESTNewsANI Pharma launches generic Prochlorperazine maleate tabletsN/A
2022-08-16 21:11 ESTNewsANI Pharmaceuticals' generic dexamethasone tablets get FDA approvalN/A
2022-08-08 18:58 ESTNewsANI Pharmaceuticals Q2 mixed earnings; raises FY 2022 revenue guidance for CortrophinN/A
2022-08-08 18:57 ESTNewsANI Pharma stock rises on Q2 revenue beat, in-line 2022 forecastN/A
2022-08-08 18:57 ESTNewsANI Pharmaceuticals, Inc. (ANIP) CEO Nikhil Lalwani on Q2 2022 Results - Earnings Call TranscriptN/A
2022-08-05 14:37 ESTNewsANI Pharmaceuticals Q2 2022 Earnings PreviewN/A
2022-06-22 15:19 ESTNewsANI Pharmaceuticals' generic drug for anxiety disorder gets FDA approvalN/A
2022-06-22 15:18 ESTNewsHot Stocks: WGO rises on earnings, ANIP gains on FDA approval, AVT pops on new partnership, while ORA fallsN/A
2022-06-02 21:40 ESTNewsANI Pharmaceuticals to cease operations at Oakville, Canada manufacturing plantN/A
2022-06-02 03:17 ESTNewsANI Pharma rises after hours on FDA approval for fludrocortisone acetate tabletsN/A
2022-05-10 23:50 ESTNewsANI Pharmaceuticals Non-GAAP EPS of -$0.12 misses by $0.21, revenue of $64.48M misses by $0.55MN/A
2022-05-10 23:49 ESTNewsANI Pharmaceuticals, Inc. (ANIP) CEO Nikhil Lalwani on Q1 2022 Results - Earnings Call TranscriptN/A
2022-05-10 01:59 ESTNewsANI Pharmaceuticals Q1 2022 Earnings PreviewN/A
2022-03-15 16:49 ESTNewsANI Pharmaceuticals Non-GAAP EPS of $0.54 misses by $0.20, revenue of $60.9M beats by $4.6MN/A
2022-03-15 16:48 ESTNewsANI Pharma reaches a seven-month low on soft guidance for 2022N/A
2022-03-15 16:47 ESTNewsANI Pharmaceuticals, Inc. (ANIP) CEO Nikhil Lalwani on Q4 2021 Results - Earnings Call TranscriptN/A
2022-03-14 23:38 ESTNewsANI Pharmaceuticals Q4 2021 Earnings PreviewN/A
2022-02-09 07:25 ESTNewsANI Pharmaceuticals: Back In The Buy ZoneN/A
2022-01-12 18:27 ESTNewsFTC final order settling antitrust charges clears way for ANI acquisition of NovitiumN/A
2021-12-21 16:27 ESTNewsANI Pharmaceuticals announces FDA approval of Mycobutin genericN/A
2021-11-11 21:20 ESTNewsANI Pharma acquisition of Novitium cleared by FTCN/A
2021-11-11 01:06 ESTNewsANI Pharma, Novitium to divest two generic products as part of mergerN/A
2021-11-04 03:50 ESTNewsANI Pharmaceuticals launches stock offeringN/A
2021-11-01 15:13 ESTNewsFDA grants expanded approval for ANI Pharmaceuticals' Cortrophin GelN/A
2021-11-01 15:13 ESTNewsANI Pharmaceuticals EPS beats by $0.31, beats on revenueN/A
2021-11-01 15:11 ESTNewsANI Pharma surges 44% following strong earnings, expanded approval; hits 52-week highN/A
2021-11-01 15:10 ESTNewsANI Pharmaceuticals, Inc. (ANIP) CEO Nikhil Lalwani on Q3 2021 Results - Earnings Call TranscriptN/A
2021-10-31 19:33 ESTNewsANI Pharmaceuticals Q3 2021 Earnings PreviewN/A
2021-10-02 06:16 ESTNewsANI Pharmaceuticals (ANIP) Investor Presentation - SlideshowN/A

About ANI Pharmaceuticals, Inc (ANIP):

ANI Pharmaceuticals, Inc., a specialty pharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, and other formulations. The company manufactures oral solid dose products; semi-solids, liquids, and topicals; and potent products, as well as performs contract manufacturing for other pharmaceutical companies. It markets its products through retail pharmacy chains, wholesalers, distributors and mail order pharmacies, and group purchasing organizations. The company was founded in 2001 and is headquartered in Baudette, Minnesota.

ANIP Quotes by TradingView

See Advanced Chart

General

  • Name ANI Pharmaceuticals, Inc
  • Symbol ANIP
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryDrug Manufacturers-Specialty & Generic
  • Full Time Employees 369
  • Last Split Factor1:6
  • Last Split Date2013-07-18
  • Fiscal Year EndDecember
  • IPO Date2000-05-05
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryPharmaceuticals
  • Gic SubIndustryPharmaceuticals
  • Web URLhttp://www.anipharmaceuticals.com
View More

Valuation

  • Trailing PE 77.58
  • Forward PE 8.31
  • Price/Sales (Trailing 12 Mt.) 1.75
  • Price/Book (Most Recent Quarter) 1.84
  • Enterprise Value Revenue 2.59
  • Enterprise Value EBITDA 19.21
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Current Year EPS Estimate $3.44
  • Next Year EPS Estimate $4.43
  • Next Quarter EPS Estimate $0.87
  • Profit Margin -11%
  • Operating Margin -2%
  • Return on Assets -1%
  • Return on Equity -11%
  • Revenue 208.48 million
  • Earnings Per Share $1.34
  • Revenue Per Share $17.43
  • Gross Profit 125.62 million
  • Quarterly Earnings Growth 19.4%
View More

Highlights

  • Market Capitalization 408.05 million
  • EBITDA 39.87 million
  • PE Ratio 55.14
  • PEG Ratio 1.06
  • Analyst Target Price $38.33
  • Book Value Per Share $16.31
View More

Share Statistics

  • Shares Outstanding 12.35 million
  • Shares Float 9.25 million
  • % Held by Insiders 474%
  • % Held by Institutions 79.46%
  • Shares Short 542783
  • Shares Short Prior Month 521318
  • Short Ratio 10.51
  • Short % of Float 7%
  • Short % of Shares Outstanding 4%
View More

Technicals

  • Beta 1.23
  • 52 Week High $52.22
  • 52 Week Low $23.55
  • 50 Day Moving Average 30.62
  • 200 Day Moving Average 29.54
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

ANI Pharmaceuticals, Inc (ANIP) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

ANI Pharmaceuticals, Inc (ANIP) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-03-09$57.25 million$0.80$0.94-15.19%
2020-09-302020-11-05$52.98 million$0.97$0.889.82%
2020-06-302020-08-06$N/A$0.69$0.75-7.59%
2020-03-312020-05-07$N/A$1.04$0.8916.85%
2019-12-312020-02-27$47.97 million$1.08$1.18-8.73%
2019-09-302019-11-06$51.34 million$1.23$1.43-13.99%
2019-06-302019-08-07$54.36 million$1.44$1.2912.06%
2019-03-312019-05-09$52.89 million$1.30$1.0524.2%
2018-12-312019-02-27$57.12 million$1.32$1.246.45%
2018-09-302018-11-06$50.7 million$1.29$1.1710.26%
2018-06-302018-08-07$47.27 million$1.13$1.34-15.67%
2018-03-312018-05-08$46.48 million$1.32$1.283.53%
2017-12-312018-02-27$47.29 million$1.08$1.053.35%
2017-09-302017-11-02$48.16 million$1.11$0.9912.12%
2017-06-302017-08-03$44.76 million$0.98$0.8613.95%
2017-03-312017-05-04$36.63 million$0.74$0.79-6.33%
2016-12-312017-03-02$38.21 million$0.90$1.10-18.18%
2016-09-302016-11-03$38.53 million$1.09$1.081.24%
2016-06-302016-08-04$31.34 million$1.11$0.7744.16%
2016-03-312016-05-05$20.56 million$0.76$0.708.57%
2015-12-312016-02-23$18.04 million$0.52$0.58-9.57%
2015-09-302015-11-03$19.97 million$0.80$0.5642.86%
2015-06-302015-08-04$19.52 million$0.55$0.541.85%
2015-03-312015-05-05$18.8 million$0.57$0.561.79%
2014-12-312015-02-19$21.04 million$0.42$0.59-28.81%
2014-09-302014-11-03$17.39 million$0.66$0.4643.48%
2014-06-302014-08-04$6.65 million-$0.21-$0.01-2000%
2014-03-312014-05-05$10.9 million$0.33$0.323.13%
2013-12-312014-02-18$15.95 million$0.41$0.2470.83%
2013-09-302013-11-07$7.84 million$0.13
2013-06-302013-08-09$6.15 million-$6.02
2013-03-312013-05-13$145040-$0.56
2012-12-312013-03-01$1.97 million-$1.10
2012-09-302012-11-08$110383-$1.62-$1.8010%
2012-06-302012-08-01$108780-$2.16-$2.4612.2%
2012-03-312012-05-08$114000-$3.24-$1.98-63.64%
2011-12-312012-03-13-$2.16-$4.0546.67%
2011-09-302011-11-09$182784-$4.32-$5.1015.29%
2011-06-302011-07-25$81003-$5.76-$6.4811.11%
2011-03-312011-05-10-$7.20-$5.18-39%
2010-12-312011-03-16-$6.48-$5.31-22.03%
2010-09-302010-11-12-$5.76-$5.04-14.29%
2010-06-302010-08-12-$6.12-$3.78-61.9%
2010-03-312010-05-14-$6.84-$3.78-80.95%
2009-12-312010-03-30-$31.32-$3.96-690.91%
2009-09-302009-11-09-$7.56-$5.76-31.25%
2009-06-302009-08-07-$6.12-$5.40-13.33%
2009-03-312009-05-11-$5.40-$5.766.25%
2008-12-312009-03-16-$1.80-$8.6479.17%
2008-09-302008-11-10-$8.64-$7.20-20%
2008-06-302008-08-11-$7.92-$5.76-37.5%
2008-03-312008-05-09-$4.68-$3.60-30%
2007-12-312008-03-17-$2.16-$2.8825%
2007-09-302007-11-13-$2.16-$3.6941.46%
2007-06-302007-08-14-$3.60-$3.24-11.11%
2007-03-312007-05-01-$2.88-$2.880%
2006-12-312007-03-08$15.84-$2.88650%
2006-09-302006-11-14-$1.08-$4.1473.91%
2006-06-302006-08-14-$3.96-$5.2224.14%
2006-03-312006-05-12-$6.12-$6.485.56%
2005-12-312006-03-31-$4.68-$4.41-6.12%
2005-09-302005-11-10-$3.60-$4.8625.93%
2005-06-302005-08-12-$4.68-$5.4013.33%
2005-03-312005-05-13-$5.04-$5.223.45%
2004-12-312005-02-15-$7.92-$6.30-25.71%
2004-09-302004-11-12-$5.76-$5.760%
2004-06-302004-08-16-$5.55
2004-03-312004-05-17-$6.12-$4.32-41.67%
2003-12-312004-03-09-$3.96
2003-09-302003-11-12-$4.31
2003-06-302003-08-16-$6.41
2003-03-312003-05-15-$4.96
2002-12-312002-12-31-$1.97
2002-09-302002-09-30-$3.91
2002-06-302002-06-30-$7.93
2002-03-312002-03-31-$5.85
2001-12-312001-12-31-$7.84
2001-09-302001-09-30$1.87

ANI Pharmaceuticals, Inc (ANIP) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

ANI Pharmaceuticals, Inc (ANIP) Chart:

ANI Pharmaceuticals, Inc (ANIP) News:

Below you will find a list of latest news for ANI Pharmaceuticals, Inc (ANIP) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

ANI Pharmaceuticals, Inc (ANIP) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2025-05-16350CALL0 0107.99TRUE00
2025-05-16400CALL0 078.56TRUE00
2025-05-16450CALL0 087.89TRUE00
2025-05-16500CALL0 077.58TRUE00
2025-05-16550CALL0 074.82TRUE00
2025-05-16600CALL0 064.05TRUE00
2025-05-16656.2CALL0 1157.28TRUE00
2025-05-16704.07CALL0 751.11FALSE00
2025-05-16751.6CALL0 2160.84FALSE00
2025-05-16802.35CALL0 10347.6FALSE00
2025-05-16850CALL0 084.82FALSE00
2025-05-16900CALL0 087.23FALSE00
2025-05-16950CALL0 083.14FALSE00
2025-05-16350PUT0 0206.52FALSE00
2025-05-16400PUT0 0143.72FALSE00
2025-05-16450PUT0 0119.17FALSE00
2025-05-16500PUT0 090.21FALSE00
2025-05-16550PUT0 094.4FALSE00
2025-05-16601.5PUT0 296.28FALSE00
2025-05-16652.41PUT1 466.86FALSE2.410
2025-05-16704.5PUT0 152.35TRUE00
2025-05-16750PUT0 054.53TRUE00
2025-05-16800PUT0 047.95TRUE00
2025-05-16850PUT0 056.69TRUE00
2025-05-16900PUT0 068.62TRUE00
2025-05-16950PUT0 076.96TRUE00
2025-06-20350CALL0 079.74TRUE00
2025-06-20400CALL0 072.39TRUE00
2025-06-20450CALL0 062.99TRUE00
2025-06-20500CALL0 062.66TRUE00
2025-06-205515.75CALL0 155.06TRUE00
2025-06-20600CALL0 050.65TRUE00
2025-06-20650CALL0 046.91TRUE00
2025-06-20700CALL0 043.76FALSE00
2025-06-20750CALL0 045.34FALSE00
2025-06-20800CALL0 052FALSE00
2025-06-20850CALL0 046.6FALSE00
2025-06-20900CALL0 072.78FALSE00
2025-06-20950CALL0 051.14FALSE00
2025-06-201000CALL0 061.64FALSE00
2025-06-20350PUT0 0129.74FALSE00
2025-06-20400PUT0 0104.93FALSE00
2025-06-20450PUT0 075.45FALSE00
2025-06-20500PUT0 085.6FALSE00
2025-06-20550PUT0 079.01FALSE00
2025-06-20600PUT0 058.78FALSE00
2025-06-20650PUT0 049.56FALSE00
2025-06-20700PUT0 048.1TRUE00
2025-06-20750PUT0 046.32TRUE00
2025-06-20800PUT0 044.51TRUE00
2025-06-20850PUT0 042.68TRUE00
2025-06-20900PUT0 047.85TRUE00
2025-06-20950PUT0 053.89TRUE00
2025-06-201000PUT0 060.58TRUE00
2025-07-18300CALL0 062.17TRUE00
2025-07-18350CALL0 084.89TRUE00
2025-07-18400CALL0 072.49TRUE00
2025-07-18450CALL0 065.17TRUE00
2025-07-18500CALL0 056.64TRUE00
2025-07-185516CALL0 155.07TRUE00
2025-07-18600CALL0 046.86TRUE00
2025-07-18659CALL3 45546.53TRUE0.40.05
2025-07-18705.55CALL0 941.02FALSE00
2025-07-18753.67CALL0 241.7FALSE00
2025-07-18802.45CALL0 142.06FALSE00
2025-07-18850CALL0 048.85FALSE00
2025-07-18900.7CALL0 145.11FALSE00
2025-07-18950CALL0 066.3FALSE00
2025-07-18300PUT0 0125.8FALSE00
2025-07-18350.95PUT0 2118.52FALSE00
2025-07-18400PUT0 099.72FALSE00
2025-07-18450PUT0 074.04FALSE00
2025-07-18500PUT0 065.16FALSE00
2025-07-18552.87PUT0 165.2FALSE00
2025-07-18603.68PUT0 151.67FALSE00
2025-07-18653.9PUT1 347.85FALSE3.90
2025-07-18706.96PUT0 13943.53TRUE00
2025-07-187518.1PUT0 042.78TRUE00
2025-07-18800PUT0 042.76TRUE00
2025-07-18850PUT0 040.58TRUE00
2025-07-18900PUT0 040.27TRUE00
2025-07-18950PUT0 045.34TRUE00
2025-10-17300CALL0 075.77TRUE00
2025-10-17350CALL0 066.21TRUE00
2025-10-17400CALL0 054.22TRUE00
2025-10-17450CALL0 051.47TRUE00
2025-10-175021CALL0 953.55TRUE00
2025-10-17550CALL0 050.08TRUE00
2025-10-17600CALL0 046.99TRUE00
2025-10-17650CALL0 043.84TRUE00
2025-10-17709.74CALL0 442.71FALSE00
2025-10-17757CALL0 1540.83FALSE00
2025-10-17804.4CALL0 1639.39FALSE00
2025-10-17852.45CALL0 440.53FALSE00
2025-10-17901.45CALL0 240.09FALSE00
2025-10-17952.05CALL0 045.1FALSE00
2025-10-171000CALL0 040.16FALSE00
2025-10-17300PUT0 0114.09FALSE00
2025-10-17350PUT0 096.92FALSE00
2025-10-17401.4PUT0 166.21FALSE00
2025-10-17452PUT0 169.15FALSE00
2025-10-17500PUT0 057.36FALSE00
2025-10-17550PUT0 051.76FALSE00
2025-10-17600PUT0 048.13FALSE00
2025-10-17657.11PUT0 144.97FALSE00
2025-10-17700PUT0 042.73TRUE00
2025-10-177515.5PUT0 4042.58TRUE00
2025-10-178015.2PUT0 1040.55TRUE00
2025-10-178518.72PUT0 2041.88TRUE00
2025-10-17900PUT0 040.88TRUE00
2025-10-17950PUT0 042.36TRUE00
2025-10-171000PUT0 041.5TRUE00

Latest ANIP Trades:

Date Shares Price
Jun 13, 2022 7:58 PM EST11182$24
Jun 13, 2022 7:58 PM EST140$24
Jun 13, 2022 7:59 PM EST100$24
Jun 13, 2022 7:59 PM EST3$23.98
Jun 13, 2022 7:59 PM EST10$24.005

ANI Pharmaceuticals, Inc (ANIP) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-06-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1023024/000110465920072312/0001104659-20-072312-index.htm
2018-09-11UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1023024/000000000018028121/0000000000-18-028121-index.htm
2018-10-18UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1023024/000000000018032671/0000000000-18-032671-index.htm
2018-11-14UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1023024/000000000018035326/0000000000-18-035326-index.htm
2020-07-14UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1023024/000000000020006407/0000000000-20-006407-index.htm
2019-01-24SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1023024/000021545719001016/0000215457-19-001016-index.htm
2020-02-04SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1023024/000083423720001478/0000834237-20-001478-index.htm
2020-11-0510-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1023024/000102302420000008/0001023024-20-000008-index.htm
2019-10-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1023024/000110465919057517/0001104659-19-057517-index.htm
2019-11-0610-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1023024/000110465919060283/0001104659-19-060283-index.htm
2019-11-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1023024/000110465919060284/0001104659-19-060284-index.htm
2019-11-268-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1023024/000110465919067257/0001104659-19-067257-index.htm
2019-12-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1023024/000110465919068992/0001104659-19-068992-index.htm
2019-12-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1023024/000110465919069229/0001104659-19-069229-index.htm
2020-01-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1023024/000110465920002449/0001104659-20-002449-index.htm
2020-01-228-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1023024/000110465920005962/0001104659-20-005962-index.htm
2020-02-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1023024/000110465920023089/0001104659-20-023089-index.htm
2020-02-2710-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1023024/000110465920025744/0001104659-20-025744-index.htm
2020-02-278-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1023024/000110465920025748/0001104659-20-025748-index.htm
2020-03-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1023024/000110465920029791/0001104659-20-029791-index.htm
2020-03-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1023024/000110465920041406/0001104659-20-041406-index.htm
2020-03-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1023024/000110465920041409/0001104659-20-041409-index.htm
2020-03-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1023024/000110465920041411/0001104659-20-041411-index.htm
2020-04-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1023024/000110465920044727/0001104659-20-044727-index.htm
2020-04-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1023024/000110465920044728/0001104659-20-044728-index.htm
2020-04-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1023024/000110465920044729/0001104659-20-044729-index.htm
2020-04-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1023024/000110465920044731/0001104659-20-044731-index.htm
2020-04-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1023024/000110465920046388/0001104659-20-046388-index.htm
2020-04-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1023024/000110465920046392/0001104659-20-046392-index.htm
2020-04-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1023024/000110465920046393/0001104659-20-046393-index.htm
2020-04-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1023024/000110465920046394/0001104659-20-046394-index.htm
2020-04-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1023024/000110465920046395/0001104659-20-046395-index.htm
2020-04-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1023024/000110465920046396/0001104659-20-046396-index.htm
2020-04-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1023024/000110465920046397/0001104659-20-046397-index.htm
2020-04-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1023024/000110465920046398/0001104659-20-046398-index.htm
2020-04-23DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1023024/000110465920049964/0001104659-20-049964-index.htm
2020-04-23DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1023024/000110465920049978/0001104659-20-049978-index.htm
2020-04-298-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1023024/000110465920052874/0001104659-20-052874-index.htm
2020-04-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1023024/000110465920053944/0001104659-20-053944-index.htm
2020-04-30DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1023024/000110465920054478/0001104659-20-054478-index.htm
2020-05-0710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1023024/000110465920057791/0001104659-20-057791-index.htm
2020-05-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1023024/000110465920057797/0001104659-20-057797-index.htm
2020-05-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1023024/000110465920060890/0001104659-20-060890-index.htm
2020-05-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1023024/000110465920061654/0001104659-20-061654-index.htm
2020-05-21DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1023024/000110465920064517/0001104659-20-064517-index.htm
2020-06-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1023024/000110465920068029/0001104659-20-068029-index.htm
2020-06-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1023024/000110465920072312/0001104659-20-072312-index.htm
2020-07-09S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1023024/000110465920082375/0001104659-20-082375-index.htm
2020-07-16CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1023024/000110465920084013/0001104659-20-084013-index.htm
2020-08-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1023024/000110465920089648/0001104659-20-089648-index.htm
2020-08-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1023024/000110465920091099/0001104659-20-091099-index.htm
2020-08-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1023024/000110465920091450/0001104659-20-091450-index.htm
2020-11-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1023024/000110465920121560/0001104659-20-121560-index.htm
2018-05-243Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1023024/000114420418030783/0001144204-18-030783-index.htm
2018-05-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1023024/000114420418030785/0001144204-18-030785-index.htm
2018-05-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1023024/000114420418030787/0001144204-18-030787-index.htm
2018-05-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1023024/000114420418030788/0001144204-18-030788-index.htm
2018-06-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1023024/000114420418033524/0001144204-18-033524-index.htm
2018-06-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1023024/000114420418033527/0001144204-18-033527-index.htm
2018-06-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1023024/000114420418033529/0001144204-18-033529-index.htm
2018-06-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1023024/000114420418033530/0001144204-18-033530-index.htm
2018-06-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1023024/000114420418033532/0001144204-18-033532-index.htm
2018-08-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1023024/000114420418041246/0001144204-18-041246-index.htm
2018-08-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1023024/000114420418042242/0001144204-18-042242-index.htm
2018-08-0710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1023024/000114420418042444/0001144204-18-042444-index.htm
2018-08-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1023024/000114420418042460/0001144204-18-042460-index.htm
2018-09-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1023024/000114420418049518/0001144204-18-049518-index.htm
2018-09-18CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1023024/000114420418049849/0001144204-18-049849-index.htm
2018-10-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1023024/000114420418055994/0001144204-18-055994-index.htm
2018-10-31CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1023024/000114420418056446/0001144204-18-056446-index.htm
2018-11-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1023024/000114420418057434/0001144204-18-057434-index.htm
2018-11-0610-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1023024/000114420418057627/0001144204-18-057627-index.htm
2018-12-278-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1023024/000114420418066411/0001144204-18-066411-index.htm
2019-01-025Annual statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1023024/000114420419000179/0001144204-19-000179-index.htm
2019-02-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1023024/000114420419004471/0001144204-19-004471-index.htm
2019-02-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1023024/000114420419008991/0001144204-19-008991-index.htm
2019-02-278-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1023024/000114420419010386/0001144204-19-010386-index.htm
2019-02-2710-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1023024/000114420419010541/0001144204-19-010541-index.htm
2019-03-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1023024/000114420419013796/0001144204-19-013796-index.htm
2019-03-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1023024/000114420419014333/0001144204-19-014333-index.htm
2019-03-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1023024/000114420419015117/0001144204-19-015117-index.htm
2019-04-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1023024/000114420419017402/0001144204-19-017402-index.htm
2019-04-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1023024/000114420419017403/0001144204-19-017403-index.htm
2019-04-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1023024/000114420419017405/0001144204-19-017405-index.htm
2019-04-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1023024/000114420419017408/0001144204-19-017408-index.htm
2019-04-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1023024/000114420419017409/0001144204-19-017409-index.htm
2019-04-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1023024/000114420419017410/0001144204-19-017410-index.htm
2019-04-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1023024/000114420419017412/0001144204-19-017412-index.htm
2019-04-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1023024/000114420419017413/0001144204-19-017413-index.htm
2019-04-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1023024/000114420419017416/0001144204-19-017416-index.htm
2019-04-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1023024/000114420419017759/0001144204-19-017759-index.htm
2019-04-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1023024/000114420419017765/0001144204-19-017765-index.htm
2019-04-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1023024/000114420419017770/0001144204-19-017770-index.htm
2019-04-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1023024/000114420419017773/0001144204-19-017773-index.htm
2019-04-04DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1023024/000114420419018181/0001144204-19-018181-index.htm
2019-04-04DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1023024/000114420419018185/0001144204-19-018185-index.htm
2019-04-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1023024/000114420419018898/0001144204-19-018898-index.htm
2019-04-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1023024/000114420419018899/0001144204-19-018899-index.htm
2019-04-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1023024/000114420419018900/0001144204-19-018900-index.htm
2019-04-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1023024/000114420419018901/0001144204-19-018901-index.htm
2019-04-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1023024/000114420419020281/0001144204-19-020281-index.htm
2019-04-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1023024/000114420419020282/0001144204-19-020282-index.htm
2019-04-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1023024/000114420419020283/0001144204-19-020283-index.htm
2019-05-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1023024/000114420419023116/0001144204-19-023116-index.htm
2019-05-0910-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1023024/000114420419024656/0001144204-19-024656-index.htm
2019-05-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1023024/000114420419024658/0001144204-19-024658-index.htm
2019-05-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1023024/000114420419025603/0001144204-19-025603-index.htm
2019-05-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1023024/000114420419026614/0001144204-19-026614-index.htm
2019-05-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1023024/000114420419026615/0001144204-19-026615-index.htm
2019-05-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1023024/000114420419026662/0001144204-19-026662-index.htm
2019-05-178-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1023024/000114420419026945/0001144204-19-026945-index.htm
2019-05-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1023024/000114420419027066/0001144204-19-027066-index.htm
2019-05-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1023024/000114420419027313/0001144204-19-027313-index.htm
2019-05-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1023024/000114420419028634/0001144204-19-028634-index.htm
2019-06-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1023024/000114420419030641/0001144204-19-030641-index.htm
2019-07-318-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1023024/000114420419036760/0001144204-19-036760-index.htm
2019-08-0710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1023024/000114420419038053/0001144204-19-038053-index.htm
2019-08-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1023024/000114420419038054/0001144204-19-038054-index.htm
2019-08-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1023024/000114420419039648/0001144204-19-039648-index.htm
2019-08-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1023024/000114420419040452/0001144204-19-040452-index.htm
2019-08-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1023024/000114420419040993/0001144204-19-040993-index.htm
2019-08-234/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1023024/000114420419041520/0001144204-19-041520-index.htm
2020-08-073Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1023024/000141588920002066/0001415889-20-002066-index.htm
2020-08-073Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1023024/000141588920002067/0001415889-20-002067-index.htm
2020-08-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1023024/000141588920002068/0001415889-20-002068-index.htm
2020-08-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1023024/000141588920002069/0001415889-20-002069-index.htm
2020-08-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1023024/000141588920002087/0001415889-20-002087-index.htm
2020-09-103Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1023024/000141588920002283/0001415889-20-002283-index.htm
2020-09-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1023024/000141588920002285/0001415889-20-002285-index.htm
2020-08-0610-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1023024/000155837020009520/0001558370-20-009520-index.htm
2020-07-17EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1023024/999999999520001852/9999999995-20-001852-index.htm
2019-02-22CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1023024/999999999719000563/9999999997-19-000563-index.htm
2019-02-22CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1023024/999999999719000565/9999999997-19-000565-index.htm
2019-03-18CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1023024/999999999719001398/9999999997-19-001398-index.htm
2019-07-01CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1023024/999999999719005909/9999999997-19-005909-index.htm
2020-04-02CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1023024/999999999720001310/9999999997-20-001310-index.htm
2020-04-02CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1023024/999999999720001312/9999999997-20-001312-index.htm
2020-04-14CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1023024/999999999720001568/9999999997-20-001568-index.htm
2020-05-15CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1023024/999999999720002915/9999999997-20-002915-index.htm

ANI Pharmaceuticals, Inc (ANIP) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of ANI Pharmaceuticals, Inc (ANIP). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 474%
Institutional Ownership: 7946%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2020-03-04THOMAS HAUGHEYDirectorBuy3,000.0045.05135,150.0011,291.00https://www.sec.gov/Archives/edgar/data/1023024/000110465920029791/0001104659-20-029791-index.htm
2018-06-06Thomas A. PennDirectorBuy1,200.0012,310.00https://www.sec.gov/Archives/edgar/data/1023024/000114420418033527/0001144204-18-033527-index.htm
2020-04-10DAVID NASHDirectorBuy7,119.0012,355.00https://www.sec.gov/Archives/edgar/data/1023024/000110465920046396/0001104659-20-046396-index.htm
2020-04-10Patrick D WalshDirectorBuy9,255.0013,046.00https://www.sec.gov/Archives/edgar/data/1023024/000110465920046395/0001104659-20-046395-index.htm
2019-03-28Thomas A. PennDirectorBuy1,991.0014,301.00https://www.sec.gov/Archives/edgar/data/1023024/000114420419017402/0001144204-19-017402-index.htm
2018-06-06Robert E. JR BrownDirectorBuy1,200.0017,768.00https://www.sec.gov/Archives/edgar/data/1023024/000114420418033524/0001144204-18-033524-index.htm
2018-06-06DAVID NASHDirectorBuy1,800.001,800.00https://www.sec.gov/Archives/edgar/data/1023024/000114420418033530/0001144204-18-033530-index.htm
2018-06-06Patrick D WalshDirectorBuy1,800.001,800.00https://www.sec.gov/Archives/edgar/data/1023024/000114420418033532/0001144204-18-033532-index.htm
2018-06-06THOMAS HAUGHEYDirectorBuy1,800.001,800.00https://www.sec.gov/Archives/edgar/data/1023024/000114420418033529/0001144204-18-033529-index.htm
2020-04-10THOMAS HAUGHEYDirectorBuy7,119.0018,410.00https://www.sec.gov/Archives/edgar/data/1023024/000110465920046398/0001104659-20-046398-index.htm
2020-05-11Patrick D WalshInterim President and CEOBuy7,050.0020,096.00https://www.sec.gov/Archives/edgar/data/1023024/000110465920060890/0001104659-20-060890-index.htm
2019-05-15ARTHUR PRZYBYLPresident and CEOSell14,633.0069.251,013,335.25202,589.00https://www.sec.gov/Archives/edgar/data/1023024/000114420419026662/0001144204-19-026662-index.htm
2019-03-28Robert E. JR BrownDirectorBuy2,584.0020,352.00https://www.sec.gov/Archives/edgar/data/1023024/000114420419017405/0001144204-19-017405-index.htm
2019-03-18ARTHUR PRZYBYLPresident and CEOSell24,802.0063.531,575,671.06205,076.00https://www.sec.gov/Archives/edgar/data/1023024/000114420419015117/0001144204-19-015117-index.htm
2019-03-19ARTHUR PRZYBYLPresident and CEOSell2,823.0063.51179,288.73205,076.00https://www.sec.gov/Archives/edgar/data/1023024/000114420419015117/0001144204-19-015117-index.htm
2019-05-16Robert E. JR BrownDirectorBuy1,042.006.366,627.1221,394.00https://www.sec.gov/Archives/edgar/data/1023024/000114420419027066/0001144204-19-027066-index.htm
2019-05-14ARTHUR PRZYBYLPresident and CEOSell5,772.0070.45406,637.40217,222.00https://www.sec.gov/Archives/edgar/data/1023024/000114420419026662/0001144204-19-026662-index.htm
2019-08-20VENTURE PARTNERS II LP MERIDIAN10% Share HolderSell5,512.0068.18375,808.162,219,259.00https://www.sec.gov/Archives/edgar/data/1023024/000114420419040993/0001144204-19-040993-index.htm
2019-08-19VENTURE PARTNERS II LP MERIDIAN10% Share HolderSell2,067.0068.30141,176.102,224,771.00https://www.sec.gov/Archives/edgar/data/1023024/000114420419040993/0001144204-19-040993-index.htm
2019-08-16VENTURE PARTNERS II LP MERIDIAN10% Share HolderSell26,349.0068.091,794,103.412,226,838.00https://www.sec.gov/Archives/edgar/data/1023024/000114420419040452/0001144204-19-040452-index.htm
2019-05-13ARTHUR PRZYBYLPresident and CEOSell9,595.0071.10682,204.50222,994.00https://www.sec.gov/Archives/edgar/data/1023024/000114420419026662/0001144204-19-026662-index.htm
2019-08-15VENTURE PARTNERS II LP MERIDIAN10% Share HolderSell9,315.0069.34645,902.102,253,187.00https://www.sec.gov/Archives/edgar/data/1023024/000114420419040452/0001144204-19-040452-index.htm
2019-05-16Robert E. JR BrownDirectorBuy1,167.0033.0038,511.0022,561.00https://www.sec.gov/Archives/edgar/data/1023024/000114420419027066/0001144204-19-027066-index.htm
2019-08-14VENTURE PARTNERS II LP MERIDIAN10% Share HolderSell26,360.0069.891,842,300.402,262,502.00https://www.sec.gov/Archives/edgar/data/1023024/000114420419040452/0001144204-19-040452-index.htm
2019-08-13VENTURE PARTNERS II LP MERIDIAN10% Share HolderSell20,821.0071.771,494,323.172,288,862.00https://www.sec.gov/Archives/edgar/data/1023024/000114420419039648/0001144204-19-039648-index.htm
2020-08-10Patrick D WalshCHAIRMAN, INTERIM PRES. & CEOBuy3,000.0030.4091,200.0023,096.00https://www.sec.gov/Archives/edgar/data/1023024/000141588920002087/0001415889-20-002087-index.htm
2019-08-12VENTURE PARTNERS II LP MERIDIAN10% Share HolderSell21,016.0071.451,501,593.202,309,683.00https://www.sec.gov/Archives/edgar/data/1023024/000114420419039648/0001144204-19-039648-index.htm
2019-08-09VENTURE PARTNERS II LP MERIDIAN10% Share HolderSell19,860.0071.701,423,962.002,330,699.00https://www.sec.gov/Archives/edgar/data/1023024/000114420419039648/0001144204-19-039648-index.htm
2019-03-28ARTHUR PRZYBYLPresident and CEOBuy37,280.00242,356.00https://www.sec.gov/Archives/edgar/data/1023024/000114420419017410/0001144204-19-017410-index.htm
2019-03-28STEPHEN P. CAREYVice President and CFOBuy12,451.0026,569.00https://www.sec.gov/Archives/edgar/data/1023024/000114420419017409/0001144204-19-017409-index.htm
2020-08-10Patrick D WalshCHAIRMAN, INTERIM PRES. & CEOBuy4,000.0030.98123,920.0027,096.00https://www.sec.gov/Archives/edgar/data/1023024/000141588920002087/0001415889-20-002087-index.htm
2020-09-08Nikhil LalwaniPRESIDENT & CEOBuy28,508.0028,508.00https://www.sec.gov/Archives/edgar/data/1023024/000141588920002285/0001415889-20-002285-index.htm
2020-04-10Robert E. JR BrownDirectorBuy7,119.0029,680.00https://www.sec.gov/Archives/edgar/data/1023024/000110465920046397/0001104659-20-046397-index.htm
2020-08-10Patrick D WalshCHAIRMAN, INTERIM PRES. & CEOBuy3,000.0030.8992,670.0030,096.00https://www.sec.gov/Archives/edgar/data/1023024/000141588920002087/0001415889-20-002087-index.htm
2019-03-28DAVID NASHDirectorBuy1,991.003,791.00https://www.sec.gov/Archives/edgar/data/1023024/000114420419017413/0001144204-19-017413-index.htm
2019-03-28Patrick D WalshDirectorBuy1,991.003,791.00https://www.sec.gov/Archives/edgar/data/1023024/000114420419017416/0001144204-19-017416-index.htm
2019-03-28THOMAS HAUGHEYDirectorBuy1,991.003,791.00https://www.sec.gov/Archives/edgar/data/1023024/000114420419017408/0001144204-19-017408-index.htm
2018-09-11Robert W SchrepferSVP - New Bus Dev & Spec SalesBuy28,688.006.60189,340.8047,842.00https://www.sec.gov/Archives/edgar/data/1023024/000114420418049518/0001144204-18-049518-index.htm
2019-03-12Robert W SchrepferSVP - New Bus Dev & Spec SalesSell5,642.0064.44363,578.3847,842.00https://www.sec.gov/Archives/edgar/data/1023024/000114420419013796/0001144204-19-013796-index.htm
2019-03-12Robert W SchrepferSVP - New Bus Dev & Spec SalesSell1,503.0064.5096,943.5047,842.00https://www.sec.gov/Archives/edgar/data/1023024/000114420419013796/0001144204-19-013796-index.htm
2019-03-13Robert W SchrepferSVP - New Bus Dev & Spec SalesSell4,651.0064.43299,645.7947,842.00https://www.sec.gov/Archives/edgar/data/1023024/000114420419013796/0001144204-19-013796-index.htm
2019-03-12Robert W SchrepferSVP - New Bus Dev & Spec SalesBuy1,503.0033.0049,599.0049,345.00https://www.sec.gov/Archives/edgar/data/1023024/000114420419013796/0001144204-19-013796-index.htm
2019-05-24DAVID NASHDirectorBuy1,445.0068.7699,358.205,236.00https://www.sec.gov/Archives/edgar/data/1023024/000114420419028634/0001144204-19-028634-index.htm
2019-03-13Robert W SchrepferSVP - New Bus Dev & Spec SalesBuy4,651.0033.00153,483.0052,493.00https://www.sec.gov/Archives/edgar/data/1023024/000114420419013796/0001144204-19-013796-index.htm
2019-03-12Robert W SchrepferSVP - New Bus Dev & Spec SalesBuy5,642.0028.76162,263.9253,484.00https://www.sec.gov/Archives/edgar/data/1023024/000114420419013796/0001144204-19-013796-index.htm
2019-05-13Robert W SchrepferSVP - New Bus Dev & Spec SalesSell2,409.0071.13171,352.1755,927.00https://www.sec.gov/Archives/edgar/data/1023024/000114420419025603/0001144204-19-025603-index.htm
2019-03-28Robert W SchrepferSVP - New Bus Dev & Spec SalesBuy12,451.0060,293.00https://www.sec.gov/Archives/edgar/data/1023024/000114420419017403/0001144204-19-017403-index.htm
2019-05-17James G. MarkenSVP Ops & Prod DevSell8,907.0070.67629,457.6961,230.00https://www.sec.gov/Archives/edgar/data/1023024/000114420419027313/0001144204-19-027313-index.htm
2019-05-15THOMAS HAUGHEYDirectorBuy2,500.0069.30173,240.006,291.00https://www.sec.gov/Archives/edgar/data/1023024/000114420419026615/0001144204-19-026615-index.htm
2020-04-10STEPHEN P. CAREYVice President and CFOBuy39,767.0063,145.00https://www.sec.gov/Archives/edgar/data/1023024/000110465920046394/0001104659-20-046394-index.htm
2019-05-14James G. MarkenSVP Ops & Prod DevSell4,917.0070.31345,714.2770,137.00https://www.sec.gov/Archives/edgar/data/1023024/000114420419026614/0001144204-19-026614-index.htm
2020-08-05Antonio R PeraDirectorBuy7,421.007,421.00https://www.sec.gov/Archives/edgar/data/1023024/000141588920002069/0001415889-20-002069-index.htm
2020-08-05Jeanne ThomaDirectorBuy7,421.007,421.00https://www.sec.gov/Archives/edgar/data/1023024/000141588920002068/0001415889-20-002068-index.htm
2019-03-28James G. MarkenSVP Ops & Prod DevBuy6,848.0075,928.00https://www.sec.gov/Archives/edgar/data/1023024/000114420419017412/0001144204-19-017412-index.htm
2020-03-03THOMAS HAUGHEYDirectorBuy2,000.0045.1890,360.008,291.00https://www.sec.gov/Archives/edgar/data/1023024/000110465920029791/0001104659-20-029791-index.htm
2020-04-10James G. MarkenSVP Ops & Prod DevBuy24,548.0085,297.00https://www.sec.gov/Archives/edgar/data/1023024/000110465920046392/0001104659-20-046392-index.htm
2020-04-10Robert W SchrepferSVP - New Bus Dev & Spec SalesBuy39,767.0093,043.00https://www.sec.gov/Archives/edgar/data/1023024/000110465920046393/0001104659-20-046393-index.htm